Who We Are
The company serves regulated and unregulated markets across Asia, Africa, and South America, with exports contributing a substantial share of business.
Manufacturing is supported by facilities benchmarked to international standards, with capabilities in tablets, capsules, injections, ointments, and powders.
Quality systems are aligned to cGMP and global regulatory expectations, with strong QA/QC controls, SOP-led batch checks, and continuous compliance monitoring.
R&D activity includes formulation development, novel drug delivery systems, and market-aligned product innovation, with focus areas such as anti-malarials, oncology, cardiology, and ophthalmology.
Our Journey
2010
Founded
2015
Global Expansion
2020
ISO Certification